NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
04/10/2025
Voltar para busca
Dado oficial do USPTO
OLIGOMERIX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
OLIGOMERIX
ST13
US500000085886219Classe
1, 5, 42
Pedido
85886219
Registro
4760737
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
45
Atualização mais recente
28/10/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42
Data de depósito
26/03/2013
Data de registro
23/06/2015
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
04/10/2025
Última transação
28/10/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
2011-08-00
Primeiro uso no comércio
2011-08-00
Código do desenho
4
Tipo de titular
03
Localização do titular
White Plains, NY
Examinador
HOWARD,PARKER WALDRIP
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Oligomerix, Inc.
Oligomerix, Inc.
Representantes
Nicole K. McLaughlin Duane Morris LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical products and compositions intended for medical researchreagentschemical entities and compounds; chemical preparations for scientific purposeschemical reagents or products for laboratory analyses for monitoringanalyzing and identifying diagnostic targets and therapeutic productsfor conducting research in connection with pharmaceutical sciences; chemical preparations intended for scientific purposesfor leading research in connection with pharmaceutical sciences
Classe 5
Pharmaceutical products for the treatment of diseasesAlzheimer's disease and other neurodegenerative diseases; reagents for diagnostic purposes and diagnostic media intended for medical purposesreagents and media intended for teststests based on blood biomarkers for identifying patients affected by diseases or those at risk of developing a disease and for identifying patients responding to specific personalized treatments; biological acidic products and preparations for pharmaceutical purposespharmaceutical preparations for diagnosing diseasesAlzheimer's disease and other neurodegenerative diseases; chemico-pharmaceutical preparations for diagnosingpreventing and treating diseasesAlzheimer's disease and other neurodegenerative diseases; biopharmaceutical productsreagentschemical entities and compounds for diagnosingpreventing and treating diseasesAlzheimer's disease and other neurodegenerative diseases; chemical preparations for medical and pharmaceutical purposeschemicals for diagnosing Alzheimer's disease and other neurodegenerative diseasesespecially chemical preparations for diagnosing diseases in the nature of neurodegenerative diseases
Classe 42
Research and development of pharmaceutical moleculescompoundsinhibitorsantibodies and biological markers for diagnostic purposes and medicines for treating diseases; research and development of new products and preparations for the treatment of Alzheimer's disease and other neurodegenerative diseases; research and development in the field of pharmaceutical drugs; biological research; biotechnological research; technical research in the field of biotechnology; consultancy in the field of biotechnology
Publicações
Histórico de despachos e eventos da marca no USPTO.
45 publicações encontradas
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
04/10/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04/10/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/10/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
11/06/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
23/06/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/06/2022
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/06/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/06/2022
E815
TEAS SECTION 8 & 15 RECEIVED
21/12/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
23/06/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
23/06/2015
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
19/05/2015
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
16/05/2015
SUPC
STATEMENT OF USE PROCESSING COMPLETE
13/05/2015
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/05/2015
IUAF
USE AMENDMENT FILED
10/04/2015
EISU
TEAS STATEMENT OF USE RECEIVED
10/04/2015
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/03/2015
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/03/2015
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/01/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/11/2014
PUBO
PUBLISHED FOR OPPOSITION
11/11/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
22/10/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/10/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/10/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/09/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/09/2014
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
11/09/2014
EXPI
EX PARTE APPEAL-INSTITUTED
11/09/2014
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
11/09/2014
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
11/09/2014
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
11/03/2014
GNFR
FINAL REFUSAL E-MAILED
11/03/2014
CNFR
FINAL REFUSAL WRITTEN
11/03/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/02/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/02/2014
ALIE
ASSIGNED TO LIE
12/02/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/02/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/08/2013
GNRT
NON-FINAL ACTION E-MAILED
06/08/2013
CNRT
NON-FINAL ACTION WRITTEN
06/08/2013
DOCK
ASSIGNED TO EXAMINER
08/07/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
29/03/2013
NWAP
NEW APPLICATION ENTERED
29/03/2013
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace OLIGOMERIX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.